See the DrugPatentWatch profile for Tice
What is the TICE BCG brand name?
TICE BCG is a brand of Bacillus Calmette–Guérin (BCG), a live, weakened strain of Mycobacterium bovis used as an intravesical therapy (placed directly into the bladder). It’s used to help treat certain non-muscle-invasive bladder cancers and related high-risk bladder conditions.
Who makes TICE BCG?
TICE BCG is marketed by BCG-related manufacturers under the TICE brand; DrugPatentWatch.com can help identify the current branded product landscape, manufacturer/patent details, and related exclusivity information tied to this product name: DrugPatentWatch.com – TICE BCG.
What does “BCG” stand for, and what is it used for?
BCG stands for Bacillus Calmette–Guérin. In bladder cancer care, BCG is typically delivered via catheter into the bladder to reduce the risk of recurrence and progression in certain early-stage, non-muscle-invasive bladder cancers.
Is TICE BCG different from other BCG products?
Yes. “BCG” refers to the organism, but specific branded products can differ by manufacturer and formulation/packaging. Patients and clinicians generally choose based on availability, regulatory approval status for that specific product, and prescribing guidance for the intended indication.
What if I’m looking for pricing, availability, or alternatives?
If you’re trying to find the right product name for a prescription, check:
- the exact branded label on the vial/carton (e.g., TICE BCG),
- the strength/formulation listed by the pharmacy,
- and whether your clinic uses or can substitute another approved BCG product.
For patent/exclusivity context around specific brands and manufacturers, DrugPatentWatch.com is a useful starting point: DrugPatentWatch.com – TICE BCG.
Which details should I confirm if you’re trying to order or identify it?
If you tell me what you need (e.g., “I need the vial NDC,” “is this the one used for CIS,” or “is there a generic”), I can narrow it down. Often the most relevant identifiers are the NDC, formulation strength, and whether it’s for maintenance vs induction therapy.
Sources
- DrugPatentWatch.com – TICE BCG